Stem Cell Reports (Aug 2018)

A Scalable and Efficient Bioprocess for Manufacturing Human Pluripotent Stem Cell-Derived Endothelial Cells

  • Haishuang Lin,
  • Qian Du,
  • Qiang Li,
  • Ou Wang,
  • Zhanqi Wang,
  • Neety Sahu,
  • Christian Elowsky,
  • Kan Liu,
  • Chi Zhang,
  • Soonkyu Chung,
  • Bin Duan,
  • Yuguo Lei

Journal volume & issue
Vol. 11, no. 2
pp. 454 – 469

Abstract

Read online

Summary: Endothelial cells (ECs) are of great value for cell therapy, tissue engineering, and drug discovery. Obtaining high-quantity and -quality ECs remains very challenging. Here, we report a method for the scalable manufacturing of ECs from human pluripotent stem cells (hPSCs). hPSCs are expanded and differentiated into ECs in a 3D thermoreversible PNIPAAm-PEG hydrogel. The hydrogel protects cells from hydrodynamic stresses in the culture vessel and prevents cells from excessive agglomeration, leading to high-culture efficiency including high-viability (>90%), high-purity (>80%), and high-volumetric yield (2.0 × 107 cells/mL). These ECs (i.e., 3D-ECs) had similar properties as ECs made using 2D culture systems (i.e., 2D-ECs). Genome-wide gene expression analysis showed that 3D-ECs had higher expression of genes related to vasculature development, extracellular matrix, and glycolysis, while 2D-ECs had higher expression of genes related to cell proliferation. : Endothelial cells (ECs) differentiated from human pluripotent stem cells (hPSCs) are needed in large numbers for regenerative medicine. In this article, Lei and colleagues describe a simple and innovative method for the scalable production of ECs from hPSCs. The method has potential to make ECs broadly available and affordable for various applications. Key words: human pluripotent stem cells, endothelial cells, 3D culture, thermoreversible hydrogel